1
|
Pouleur AC, Barkoudah E, Uno H, et al:
Pathogenesis of sudden unexpected death in a clinical trial of
patients with myocardial infarction and left ventricular
dysfunction, heart failure, or both. Circulation. 122:597–602.
2010. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wang H and Eitzman DT: Acute myocardial
infarction leads to acceleration of atherosclerosis.
Atherosclerosis. 229:18–22. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ross R: Atherosclerosis is an inflammatory
disease. Am Heart J. 138:419–420. 1999. View Article : Google Scholar
|
4
|
Hong C, Zhu F, Du D, Pilgram TK, Sicard GA
and Bae KT: Coronary artery calcification and risk factors for
atherosclerosis in patients with venous thromboembolism.
Atherosclerosis. 183:169–174. 2005. View Article : Google Scholar : PubMed/NCBI
|
5
|
McGeachie M, Ramoni RL, Mychaleckyj JC, et
al: Integrative predictive model of coronary artery calcification
in atherosclerosis. Circulation. 120:2448–2454. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Westenfeld R, Schäfer C, Smeets R, et al:
Fetuin-A (AHSG) prevents extraosseous calcification induced by
uraemia and phosphate challenge in mice. Nephrol Dial Transplant.
22:1537–1546. 2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Anderson L and Anderson NG: High
resolution two-dimensional electrophoresis of human plasma
proteins. Proc Natl Acad Sci USA. 74:5421–5425. 1977. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lee CC, Bowman BH and Yang FM: Human alpha
2-HS-glycoprotein: the A and B chains with a connecting sequence
are encoded by a single mRNA transcript. Proc Natl Acad Sci USA.
84:4403–4407. 1987. View Article : Google Scholar : PubMed/NCBI
|
9
|
Jahnen-Dechent W, Schinke T, Trindl A, et
al: Cloning and targeted deletion of the mouse fetuin gene. J Biol
Chem. 272:31496–31503. 1997. View Article : Google Scholar
|
10
|
Auberger P, Falquerho L, Contreres JO, et
al: Characterization of a natural inhibitor of the insulin receptor
tyrosine kinase: cDNA cloning, purification and anti-mitogenic
activity. Cell. 58:631–640. 1989. View Article : Google Scholar : PubMed/NCBI
|
11
|
Dahlman I, Eriksson P, Kaaman M, et al:
alpha2-Heremans-Schmid glycoprotein gene polymorphisms are
associated with adipocyte insulin action. Diabetologia.
47:1974–1979. 2004. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lebreton JP, Joisel F, Raoult JP, Lannuzel
B, Rogez JP and Humbert G: Serum concentration of human alpha 2 HS
glyco-protein during the inflammatory process: evidence that alpha
2 HS glycoprotein is a negative acute-phase reactant. J Clin
Invest. 64:1118–1129. 1979. View Article : Google Scholar : PubMed/NCBI
|
13
|
Schafer C, Heiss A, Schwarz A, et al: The
serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a
systemically acting inhibitor of ectopic calcification. J Clin
Invest. 112:357–366. 2003. View
Article : Google Scholar : PubMed/NCBI
|
14
|
Rizzu P and Baldini A: Three members of
the human cystatin gene superfamily, AHSG, HRG and KNG, map within
one megabase of genomic DNA at 3q27. Cytogenet Cell Genet.
70:26–28. 1995. View Article : Google Scholar
|
15
|
Osawa M, Umetsu K, Sato M, et al:
Structure of the gene encoding human alpha 2-HS glycoprotein
(AHSG). Gene. 196:121–125. 1997. View Article : Google Scholar : PubMed/NCBI
|
16
|
Osawa M, Yuasa I, Kitano T, et al:
Haplotype analysis of the human alpha2-HS glycoprotein (fetuin)
gene. Ann Hum Genet. 65:27–34. 2001. View Article : Google Scholar : PubMed/NCBI
|
17
|
Stenvinkel P, Pecoits-Filho R, Lindholm B
and DialGene C: Gene polymorphism association studies in dialysis:
the nutrition-inflammation axis. Semin Dial. 18:322–330. 2005.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Weikert C, Stefan N, Schulze MB, et al:
Plasma fetuin-a levels and the risk of myocardial infarction and
ischemic stroke. Circulation. 118:2555–2562. 2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Mehrotra R, Westenfeld R, Christenson P,
et al: Serum fetuin-A in nondialyzed patients with diabetic
nephropathy: relationship with coronary artery calcification.
Kidney Int. 67:1070–1077. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Lim P, Collet JP, Moutereau S, et al:
Fetuin-A is an independent predictor of death after ST-elevation
myocardial infarction. Clin Chem. 53:1835–1840. 2007. View Article : Google Scholar : PubMed/NCBI
|
21
|
Fisher E, Stefan N, Saar K, et al:
Association of AHSG gene polymorphisms with fetuin-A plasma levels
and cardiovascular diseases in the EPIC-Potsdam study. Circ
Cardiovasc Genet. 2:607–613. 2009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Fried LP, Borhani NO, Enright P, et al:
The cardiovascular health study: design and rationale. Ann
Epidemiol. 1:263–276. 1991. View Article : Google Scholar : PubMed/NCBI
|
23
|
Friedewald WT, Levy RI and Fredrickson DS:
Estimation of the concentration of low-density lipoprotein
cholesterol in plasma, without use of the preparative
ultracentrifuge. Clin Chem. 18:499–502. 1972.PubMed/NCBI
|
24
|
Chen W: Rapid isolation of DNA from human
peripheral blood. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 14:141–142.
1992.In Chinese. PubMed/NCBI
|
25
|
Murray CJ and Lopez AD: Evidence-based
health policy-lessons from the global burden of disease study.
Science. 274:740–743. 1996. View Article : Google Scholar : PubMed/NCBI
|
26
|
Yusuf S, Reddy S, Ounpuu S and Anand S:
Global burden of cardiovascular diseases: part I: general
considerations, the epidemiologic transition, risk factors and
impact of urbanization. Circulation. 104:2746–2753. 2001.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Wilson PW, D’Agostino RB, Levy D, Belanger
AM, Silbershatz H and Kannel WB: Prediction of coronary heart
disease using risk factor categories. Circulation. 97:1837–1847.
1998. View Article : Google Scholar : PubMed/NCBI
|
28
|
Maseri A and Fuster V: Is there a
vulnerable plaque? Circulation. 107:2068–2071. 2003. View Article : Google Scholar : PubMed/NCBI
|
29
|
Holmes DR Jr, Hartzler GO, Smith HC and
Fuster V: Coronary artery thrombosis in patients with unstable
angina. Br Heart J. 45:411–416. 1981. View Article : Google Scholar : PubMed/NCBI
|
30
|
Mandelkorn JB, Wolf NM, Singh S, et al:
Intracoronary thrombus in nontransmural myocardial infarction and
in unstable angina pectoris. Am J Cardiol. 52:1–6. 1983. View Article : Google Scholar : PubMed/NCBI
|
31
|
Ambrose JA, Winters SL, Arora RR, et al:
Coronary angiographic morphology in myocardial infarction: a link
between the pathogenesis of unstable angina and myocardial
infarction. J Am Coll Cardiol. 6:1233–1238. 1985. View Article : Google Scholar : PubMed/NCBI
|
32
|
Doherty TM, Detrano RC, Mautner SL,
Mautner GC and Shavelle RM: Coronary calcium: the good, the bad and
the uncertain. Am Heart J. 137:806–814. 1999. View Article : Google Scholar : PubMed/NCBI
|
33
|
Shemesh J, Stroh CI, Tenenbaum A, et al:
Comparison of coronary calcium in stable angina pectoris and in
first acute myocardial infarction utilizing double helical
computerized tomography. Am J Cardiol. 81:271–275. 1998. View Article : Google Scholar : PubMed/NCBI
|
34
|
Raggi P, Cooil B, Shaw LJ, et al:
Progression of coronary calcium on serial electron beam tomographic
scanning is greater in patients with future myocardial infarction.
Am J Cardiol. 92:827–829. 2003. View Article : Google Scholar : PubMed/NCBI
|
35
|
Vliegenthart R, Oudkerk M, Song B, van der
Kuip DA, Hofman A and Witteman JC: Coronary calcification detected
by electron-beam computed tomography and myocardial infarction. The
rotterdam coronary calcification study. Eur Heart J. 23:1596–1603.
2002. View Article : Google Scholar : PubMed/NCBI
|
36
|
Schinke T, Amendt C, Trindl A, Pöpschke O,
Müller-Esterl W and Jahnen-Dechent W: The serum protein alpha2-HS
glycoprotein/fetuin inhibits apatite formation in vitro and in
mineralizing calvaria cells. A possible role in mineralization and
calcium homeostasis. J Biol Chem. 271:20789–20796. 1996. View Article : Google Scholar : PubMed/NCBI
|
37
|
Merx MW, Schäfer C, Westenfeld R, et al:
Myocardial stiffness, cardiac remodeling and diastolic dysfunction
in calcification-prone fetuin-A-deficient mice. J Am Soc Nephrol.
16:3357–3364. 2005. View Article : Google Scholar : PubMed/NCBI
|
38
|
Stefan N, Hennige AM, Staiger H, et al:
Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with
insulin resistance and fat accumulation in the liver in humans.
Diabetes Care. 29:853–857. 2006. View Article : Google Scholar : PubMed/NCBI
|
39
|
Ketteler M, Bongartz P, Westenfeld R, et
al: Association of low fetuin-A (AHSG) concentrations in serum with
cardiovascular mortality in patients on dialysis: a cross-sectional
study. Lancet. 361:827–833. 2003. View Article : Google Scholar : PubMed/NCBI
|
40
|
Kaden JJ, Reinöhl JO, Blesch B, et al:
Systemic and local levels of fetuin-A in calcific aortic valve
stenosis. Int J Mol Med. 20:193–197. 2007.PubMed/NCBI
|
41
|
Ix JH, Chertow GM, Shlipak MG, Brandenburg
VM, Ketteler M and Whooley MA: Association of fetuin-A with mitral
annular calcification and aortic stenosis among persons with
coronary heart disease: data from the Heart and Soul Study.
Circulation. 115:2533–2539. 2007. View Article : Google Scholar : PubMed/NCBI
|
42
|
Afsar CU, Uzun H, Yurdakul S, et al:
Association of serum fetuin-A levels with heart valve calcification
and other biomarkers of inflammation among persons with acute
coronary syndrome. Clin Invest Med. 35:E206–E215. 2012.PubMed/NCBI
|